SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Pernix Therapeutics Holdings Inc (PTX)

PTX RSS Feed
Add PTX Price Alert      Hide Sticky   Hide Intro
Moderator: nathanial, Popeye, Briley
Search This Board: 
Last Post: 3/25/2017 8:08:08 AM - Followers: 124 - Board type: Free - Posts Today: 0

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
 
    



 
 
 


 

PRESS RELEASES (Investor Presentation located Here)


July 7, 2016  Pernix Therapeutics Announces Restructuring  of Sales Force and Operations
June 16, 2016  Pernix Therapeutics Announces Positive Phase IV Results of Silenor® vs. Zolpidem Head-to-Head Arousability Study
May 25, 2016  Pernix Therapeutics Announces the Issuance of Three New Orange Book Patents for Zohydro® ER with BeadTek™
May 11, 2016  Pernix Therapeutics Announces CEO Transition
May 9, 2016  Pernix Therapeutics Overcomes Challenge to Treximet® ‘183 Patent
May 5, 2016  Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update
April 28, 2016  Pernix Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016
March 10, 2016  Pernix Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update
March 2, 2016  Pernix Therapeutics Files Citizen Petition Following Issuance of U.S. Patent Number 9,265,760 (‘760 Patent) Covering Safety Information Related to Dosing Patients with Zohydro ER® with BeadTek™ CII
February 24, 2016  Pernix Therapeutics to Report Fourth Quarter and Full-Year 2015 Financial Results on Thursday, March 10, 2016
February 23, 2016  Pernix Therapeutics Announces the Issuance of New Orange Book Patent for Zohydro® ER With BeadTek™ CII
UPDATED 7/7/2016
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#2857  Sticky Note Pernix Therapeutics Investor Watchlist: updated 7/23/2016 humboldt111502 07/24/16 10:06:46 AM
#5169   FY15 rev~175M FY16 rev~155M (9 mos per filing $110M+$45M StocksInvestor 03/25/17 08:08:08 AM
#5168   Hmmmm... I wonder what he thinks about the Ditryin 03/24/17 11:04:43 PM
#5167   Lmao ! StocksInvestor 03/24/17 09:28:43 PM
#5166   PM me if you can. buckiii2 03/24/17 08:14:32 PM
#5165   Just a few questions for you... bud_fox 03/24/17 06:49:11 PM
#5164   He just went back in his office buckiii2 03/24/17 03:56:27 PM
#5163   A close at 4 or better would be nice. nathanial 03/24/17 03:25:26 PM
#5162   It was after market close, hmmmm...:) bud_fox 03/24/17 03:24:11 PM
#5161   Yes interesting day over there. Up $9.00 HOD bud_fox 03/24/17 03:22:38 PM
#5160   Did your Dr. do any research on Zohydro? Ditryin 03/24/17 03:19:43 PM
#5159   Could be, but long term more than htgm, Gigi70 03/24/17 01:11:46 PM
#5158   could be next Htgm...only 9.5m shares outstanding!!!!! StocksInvestor 03/24/17 12:27:10 PM
#5157   Surprised at the low volume a few days Dbe1919 03/24/17 11:25:36 AM
#5156   I have seen this math before done it StocksInvestor 03/24/17 06:36:05 AM
#5155   Whatever the current SP is at the time DeFran 03/24/17 03:24:35 AM
#5154   It would. I'm sure they all know how presence 03/23/17 10:15:29 PM
#5153   FWIW I got my pain management Dr to buckiii2 03/23/17 09:53:29 PM
#5152   Thanks for the feedback. If ER is going StocksInvestor 03/23/17 09:41:51 PM
#5151   He will not be able to comment on presence 03/23/17 05:15:56 PM
#5150   Do you guys think CEO and team has StocksInvestor 03/23/17 05:07:30 PM
#5149   I agree. The accumulation and inability to push presence 03/23/17 03:22:23 PM
#5148   Not a problem at all! I think starting DeFran 03/23/17 03:21:01 PM
#5147   Thanks, DeFran! presence 03/23/17 03:12:39 PM
#5146   That article was written prior to the release DeFran 03/23/17 03:11:49 PM
#5145   That GSK settlement payout schedule still amazes me. nathanial 03/23/17 02:41:24 PM
#5144   I think the 8-K should have been dissected presence 03/23/17 01:11:33 PM
#5143   http://www.gurufocus.com/news/494636/pernix-ptx-stock-an-investors-rationale-to- Popeye 03/23/17 12:28:06 PM
#5142   Co do have lot of debt over $300m....one StocksInvestor 03/22/17 04:53:20 PM
#5141   Because they would not only get Treximet back Ditryin 03/22/17 01:10:14 PM
#5140   Isn't GSK sold their drug to them so StocksInvestor 03/22/17 12:56:40 PM
#5139   One more thought as to why GSK is nsomniyak 03/22/17 12:11:37 PM
#5138   I am assuming that PTX is already in nsomniyak 03/22/17 12:07:06 PM
#5137   Agreed. No one who is owed that presence 03/21/17 11:33:05 PM
#5136   No it's because GSK will be the one Ditryin 03/21/17 11:28:52 PM
#5135   This baby is going to gap up big presence 03/21/17 11:06:06 PM
#5134   They may be in talks (PTX and gsk) Kypee 03/21/17 09:08:07 PM
#5133   Did ptx just made a joke out of StocksInvestor 03/21/17 08:31:02 PM
#5132   Agreed, take it all with a grain of bud_fox 03/21/17 08:03:50 PM
#5131   Not sure but markets were down across the bud_fox 03/21/17 08:02:07 PM
#5130   So the mad rush yesterday was in anticipation nathanial 03/21/17 07:36:00 PM
#5129   I'm on ST all the time. I Dbe1919 03/21/17 07:20:23 PM
#5128   If you folks want to add a piece bud_fox 03/21/17 07:14:58 PM
#5127   GSK wants to be notified of any purchase bud_fox 03/21/17 07:10:13 PM
#5126   Man, that's some very lenient terms. Any buy nathanial 03/21/17 07:08:34 PM
#5125   You gotta wonder why GSK would be so Dbe1919 03/21/17 07:01:02 PM
#5124   8-K filed earlier. Looks to be a bud_fox 03/21/17 06:50:21 PM
#5123   Was nice. nathanial 03/21/17 11:35:57 AM
#5122   Yeah that really nice! BPTH2008 03/21/17 09:53:04 AM
#5121   Pre market: 4.18-4.20. nathanial 03/21/17 09:15:00 AM
#5120   $PTX ~ Chart looking sweet here. Need bud_fox 03/21/17 07:47:58 AM
PostSubject